Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mydecine Innovations Group Inc (OP: MYCOF ) 0.0092 -0.0005 (-5.15%) Streaming Delayed Price Updated: 10:28 AM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Mydecine Innovations Group Inc < Previous 1 2 3 4 Next > InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Board Approves Issuance of Shares for Debt Settlement March 21, 2024 Via Investor Brand Network Mydecine Innovations Group Inc. Announces Share for Debt Settlement March 20, 2024 VANCOUVER, BC / TheNewswire / 20 March 2024 -- Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE: MYIG) (the “Company” or “Mydecine”) announced that it has entered into a debt... Via TheNewswire.com InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Compounds Receive USPTO Notice of Allowances February 08, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces USPTO Issues Notice of Allowance for MYCO-005 Compound December 18, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound December 18, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Updates Special Access Program November 29, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Files Prospectus Supplement, Closes Share Subscription Agreements October 31, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Reports on Company Progress in Q4 2023 Update October 26, 2023 Via Investor Brand Network Exposures Product Safety Mydecine Provides Q4 2023 Business Update October 26, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Mydecine Innovations Group gearing up for human trials after completing Aquis listing October 18, 2023 Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) CEO Joshua Bartch speaks to Thomas Warner from Proactive London about the biotechnology company's ambitious goals in the psychedelic medicine... Via TheNewswire.com InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Starts Trading on the AQSE Growth Market October 10, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings October 10, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) Common Shares Begin Listing on CSE October 06, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Expects UK Dual Listing Admission Next Month September 28, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Receives CSE Listing Conditional Approval August 31, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Mydecine Announces Conditional Approval of CSE Listing August 30, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Leadership Update July 24, 2023 Via Investor Brand Network InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Reports on Special Meeting July 06, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Files Prospectus Supplement, Closes 1st Tranche of Subscription Agreement, Reappoints Board Member May 30, 2023 Via Investor Brand Network Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors May 29, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Results of Annual General Shareholders Meeting May 11, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Mydecine Reports its 2023 Annual General Shareholders' Meeting Results May 10, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Positive Preclinical Results on MYCO-006 Series April 24, 2023 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property Product Safety Mydecine Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting MDMA Analogues April 24, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Closes on Share Subscription Agreement April 20, 2023 Via Investor Brand Network InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Filing of Prospectus Supplement, First Tranche Closing April 11, 2023 Via Investor Brand Network InvestorNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Issues Corporate Update April 03, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Mydecine Innovations Group Provides Corporate Update April 03, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire Mydecine Reports Financial Results for the Year Ended December 2022 March 31, 2023 From Mydecine Innovations Group Inc. Via GlobeNewswire BioMedNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Reports on Debt Settlement Agreements March 06, 2023 Via Investor Brand Network < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.